Looking to expand your partner network with leading companies like Ipsen? Consider joining Inpart's global network for free.
Podcast 1 Dec 2023
Ipsen drug gives hope for liver disease patients
On the podcast this week, we are looking at recent advances in treating certain liver diseases. Jennifer Schranz is senior vice president and global head of rare diseases in the R&D division at Ipsen, and she discusses a breakthrough treatment for primary biliary cholangitis and cholestatic liver disease. What is primary biliary cholangitis? Primary biliary […]
